The Lighthouse II Project will investigate whether targeting HERVs with anti-retroviral therapy might slow disease progression in patients with MND/ALS.
Clinical trial for an investigation drug WVE-004, specifically designed for MND caused by a mutation in the C9orf72 gene or C9orf72-associated frontotemporal dementia (FTD).
Understanding the relationship between the deposition of protein aggregates and the death/dysfunction of various brain cells.
This study aims to estimate the economic costs associated with the care of people with MND for future public policy making and planning.
Determining the relationship between MND and a range of known or suspected occupational or environmental exposures in NZ.
Helping MND researchers by assisting in research planning and finding study participants.
Researching pulmonary function to assist quality improvement and new tests.
Researching end of life care for neurodegenerative conditions
Research into supporting adults with complex motor and speech disorders.
Assessing the impact of swallowing skill protocol in patients with ALS.
Striving to improve the lives of people with swallowing difficulties through improved assessment, treatment and medical education in the field of dysphagia.
Understanding the role that protein aggregates, in particular those from the protein TDP-43, play in MND disease progression.
Please scroll down and hover over each image to read a short blurb about that specific researcher or lab and click the image to be taken to the full profile. Alternatively you can access specific profiles directly via links available in the Research Profiles box. If you think your research should also be profiled here please contact us.